The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease

Neuropathology and Applied Neurobiology

Volumn 34, Issue 2, 2008, Pages 194-204

  Jiang, Z J ^a   Richardson, J S ^a,b   Yu, P H ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Alzheimer's disease; Cerebral amyloid angiopathy; Formaldehyde; Immunohistochemistry; Semicarbazide sensitive amine oxidase

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINE OXIDASE (COPPER CONTAINING); AMYLOID BETA PROTEIN; METHYLAMINE;

ALZHEIMER DISEASE; ARTICLE; BLOOD VESSEL; BRAIN BLOOD VESSEL; CONTROLLED STUDY; CROSS LINKING; DEAMINATION; ENZYME SUBSTRATE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UMBILICAL CORD; VASCULAR AMYLOIDOSIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINE OXIDASE (COPPER-CONTAINING); AMYLOID BETA-PROTEIN; BLOOD VESSELS; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; UMBILICAL CORD;

EID: 40149085096     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2007.00886.x     Document Type: Article

References (43)

1. Yu PH. Semicarbazide-sensitive amine oxidase (SSAO). In Encyclopedia of Molecular Medicine, Vol. 5. New York : John Wiley Inc., 2002 2887 8
2. Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med 1998 188 : 17 27
3. Abella A, Garcia-Vicente S, Viguerie N, Ros-Baro A, Camps M, Palacin M, Zorzano A, Marti L. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 2004 47 : 429 38
4. Yu PH. Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase. J Pharm Pharmacol 1990 42 : 882 4
5. Lyles GA, Chalmers J. The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochem Pharmacol 1992 31 : 1417 24
6. Chen K, Maley J, Yu PH. Potential implications of endogenous aldehydes in β-amyloid misfolding, oligomerization and fibrillogenesis. J Neurochem 2006 99 : 1413 24
7. Boomsma F, Derks FHM, van den Meiracker AH, Man in'tVeld A, Schalekamp MADH. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemolglobin. Clin Sci 1995 88 : 675 9
8. Garpenstrand H, Ekblom J, Backlund LB, Oreland L, Rosenqvist U. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in type 2 diabetes mellitus complicated by retinopathy. Diabet Med 1999 16 : 514 21
9. Boomsma F, van Veldhuisen DJ, de Kam PJ, Man in'tVeld A, Mosterd A, Lie KI, Schalekamp MA. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res 1997 33 : 387 91
10. Karadi I, Meszaros Z, Csanyi A, Szombathy T, Hosszufalusi N, Romics L, Magyar K. Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis. Clin Chim Acta 2002 323 : 139 46
11. Ishizaki F. Plasma benzylamine oxidase activity in cerebrovascular disease. Eur Neurol 1990 30 : 104 7
12. del Mar Hernandez M, Esteban M, Szabo P, Boada M, Unzeta M. Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging. Neurosci Lett 2005 384 : 183 7
13. Yu PH, Wright S, Fan EH, Lun ZR, Gubisne-Harberle D. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim Biophys Acta - Proteins Proteomics 2003 1647 : 193 9
14. Yu PH. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia. Med Hypotheses 2001 57 : 175 9
15. Perlmutter LS, Chui HC. Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res Bull 1990 24 : 677 86
16. Kalaria RN. The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann N Y Acad Sci 1999 893 : 113 25
17. Hachinski V, Munoz DG. Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon? Ann N Y Acad Sci 1997 826 : 1 6
18. Miyakawa T. Electron microscopy of amyloid fibrils and microvessels. Ann N Y Acad Sci 1997 826 : 25 34
19. Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neural Sci 1993 116 : 135 41
20. Hardy J, Selkoe D. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002 297 : 353 6
21. Richardson JS, Zhou Y, Kumar U. Free radicals in the neurotoxic actions of beta-amyloid. Ann N Y Acad Sci 1996 777 : 362 7
22. Zhou Y, Gopalakrishnan V, Richardson JS. The actions of neurotoxic beta amyloid on calcium homeostasis and viability of PC 12 cells are blocked by antioxidants but not by calcium channel blockers. J Neurochem 1996 67 : 1419 25
23. Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 2002 109 : 813 36
24. Zuo DM, Yu PH. Semicarbazide-sensitive amine oxidase and monoamine oxidase in rat brain microvessels, meninges, retina and eye sclera. Brain Res Bull 1994 33 : 307 11
25. Ferrer I, Lizcano JM, Hernandez M, Unzeta M. Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurosci Lett 2002 321 : 21 4
26. Jaakkola K, Nikula T, Holopainen R, Vahasilta T, Matikainen MT, Laukkanen ML, Huupponen R, Halkola L, Nieminen L, Hiltunen J, Parviainen S, Clark MR, Knuuti J, Savunen T, Kaapa P, Voipio-Pulkk LM, Jalkanen S. In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am J Pathol 2000 157 : 463 71
27. McGeer PL, McGeer EG. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 2001 22 : 799 809
28. Damas J, Liegeois JF. The inflammatory reaction induced by formalin in the rat paw. Naunyn Schmiedebergs Arch Pharmacol 1999 359 : 220 7
29. Gubisne-Haberle D, Hill W, Kazachkov M, Richardson JS, Yu PH. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine. J Pharmacol Exp Ther 2004 310 : 1125 32
30. Murray IV, Liu L, Komatsu H, Uryu K, Xiao G, Lawson JA, Axelsen PH. Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins. J Biol Chem 2007 282 : 9335 45
31. Premkumar DR, Kalaria RN. Altered expression of amyloid beta precursor mRNAs in cerebral vessels, meninges, and choroid plexus in Alzheimer's disease. Ann N Y Acad Sci 1996 777 : 288 92
32. Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lenting PJ, Van Nostrand WE, Zlokovic BV. LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms. Neuron 2004 43 : 333 44
33. Zlokovic BV. Clearing amyloid through the blood-brain barrier. J Neurochem 2004 89 : 807 11
34. Tanzi RE, Moir RD, Wagner SL. Clearance of Alzheimer's Aβ peptide: the many roads to perdition. Neuron 2004 43 : 605 8
35. DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM. Brain to plasma amyloid-β efflux: a measure of brain amyloid burden in a mouse model. Science 2002 295 : 2264 7
36. Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001 64 : 575 611
37. Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 2004 363 : 1139 46
38. Roher AE, Esh C, Rahman A, Kokjohn TA, Beach TG. Atherosclerosis of cerebral arteries in Alzheimer's disease. Stroke 2004 35 : 2623 7
39. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999 53 : 1937 42
40. Yu PH, Zuo DM. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes 1993 42 : 594 603
41. Yu PH, Wang M, Deng YL, Fan H, Shira-Bock L. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet. Diabetologia 2002 45 : 1255 62
42. Boomsma F, de Kam PJ, Tjeerdsama G, van Den Meiracker AH, van Veldhuisen DJ. Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure. Eur Heart J 2000 21 : 1859 63
43. Gitter BD, Cox LM, Rydel RE, May PC. Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proc Natl Acad Sci USA 1995 92 : 10738 41